FTD clinical phenotypes associated with FTLD-Tau and FTLD-TDP43 are clinically indistinguishable, and there are currently no diagnostic markers available in vivo to reliably predict the underlying neuropathology [4, 8–10]. This evidence concerns the gene TARDBP and frontotemporal dementia.